Clearance Summary
ANTLIA III WOUND TREATMENT SYSTEM received FDA 510(k) clearance under submission number K111333, sponsored by Innovative Therapies, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2011-08-08.
- Submission: K111333
- Applicant / Sponsor: Innovative Therapies, Inc.
- Clearance pathway: Special
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4780
- Decision date: 2011-08-08
Classification & Regulation
This clearance is catalogued under FDA product code OMP and 21 CFR 878.4780, within the General, Plastic Surgery review panel as a Class II device.